Arcturus Therapeutics Holdings (ARCT) Assets (2018 - 2026)

Arcturus Therapeutics Holdings' Assets history runs 9 years deep, the most recent figure standing at $245.4 million for Q1 2026.

• Quarterly Assets fell 26.03% year-over-year to $245.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $245.4 million (down 26.03% YoY) and the FY2025 annual result came in at $271.1 million, down 21.19% from the prior year.
• Assets was $245.4 million for Q1 2026 at Arcturus Therapeutics Holdings, down from $271.1 million in the prior quarter.
• Across five years, Assets topped out at $470.9 million in Q1 2023 and bottomed at $245.4 million in Q1 2026.
• A 5-year average of $363.2 million and a median of $344.1 million in 2024 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets sank 32.43% — and 2023, when it surged 55.86%.
• Arcturus Therapeutics Holdings' Assets stood at $450.4 million in 2022, then declined by 4.66% to $429.4 million in 2023, then fell by 19.87% to $344.1 million in 2024, then declined by 21.19% to $271.1 million in 2025, then decreased by 9.49% to $245.4 million in 2026.
• Business Quant data shows ARCT's Assets at $245.4 million in Q1 2026, $271.1 million in Q4 2025, and $282.3 million in Q3 2025.